Faslodex (fulvestrant), a new drug for metastatic breast cancer

You'll start hearing about Faslodex (fulvestrant), a new drug for metastatic breast cancer.

It's awaiting approval in Canada...and just became available in the U.S.

Faslodex is a once-monthly injection to treat postmenopausal women whose cancer progresses on tamoxifen or another antiestrogen.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote